Pure Global

MERCK S.A. - Authorized Company ProfileMERCK S.A.

Explore comprehensive authorized company profile for MERCK S.A. through Pure Global AI's free Colombia medical device database. This company manufactures 251 medical devices registered with INVIMA across 5 risk classes. Their registration history spans from Mar 20, 2024 to Aug 01, 2033.

This page provides detailed insights including recent registrations, risk class distribution (II: 22, I: 205, Unspecified: 15, and more), and complete regulatory information from the official Colombia INVIMA medical device database with bilingual Spanish/English support. Pure Global AI offers free access to Colombia's complete medical device registry.

Free Authorized Company Profile
Powered by Pure Global AI
251 Devices
5 Risk Classes
MERCK S.A.
MERCK S.A.
Authorized Company
251
Total Devices
5
Risk Classes
2024
Earliest
2033
Latest
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Recent Registrations
Latest 20 INVIMA device registrations

AUTOINYECTOR REBISMART 3.0 / REBISMART 3.0

REBISMART 3.0 / REBISMART 3.0 AUTOINJECTOR

a140fc53eca4be1e1dc4b7f565e143aa

IIa
Aug 01, 2033

ULTRA PHYSIOLOGICAL FLUID KIT

ULTRA PHYSIOLOGICAL FLUID KIT

a82cc145f5db0248247c2de564e4c88a

II
Dec 16, 2031

LINCOMYCIN HYDROCHLORIDE

LINCOMYCIN HYDROCHLORIDE

792f3feccb0a7c01f4be875d56b65260

I
Jan 10, 2031

DULBECCO’S PHOSPHATE BUFFERED SALINE

DULBECCO'S PHOSPHATE BUFFERED SALINE

dec2a34e027b205eaf1bde8470c0bbfc

I
Jan 10, 2031

EARLE’S BALANCED SALTS (EBSS)

EARLE'S BALANCED SALTS (EBSS)

7bf168a68bb28e55edad251b5d55be92

I
Jan 10, 2031

ANTIBIOTIC ANTIMYCOTIC SOLUTION (100×), STABILIZED

ANTIBIOTIC ANTIMYCOTIC SOLUTION (100×), STABILIZED

253cd9c6db1960e6617487bf3ae61ba3

I
Jan 10, 2031

DIHYDROSTREPTOMYCIN SESQUISULFATE

DIHYDROSTREPTOMYCIN SESQUISULFATE

dcb940b23b6da8fe4a272599fd5ec1ca

I
Jan 10, 2031

HUMAN MESENCHYMAL-XF EXPANSION MEDIUM

HUMAN MESENCHYMAL-XF EXPANSION MEDIUM

2474add6c5bff6c694be16d9551f26af

I
Jan 10, 2031

DIMETHYL SULFOXIDE CELL CULTURE TESTED

DIMETHYL SULFOXIDE CELL CULTURE TESTED

4714cf0d7a951834e3f07c5dd6b35190

I
Jan 10, 2031

DMEM/NUTRIENT MIXTURE F-12 HAM

DMEM/NUTRIENT MIXTURE F-12 HAM

76faef02782db1492a3fc94b78765218

I
Jan 10, 2031

DULBECCO’S MODIFIED EAGLE’S MEDIUM-HIGH GLUCOSE

DULBECCO'S MODIFIED EAGLE'S MEDIUM-HIGH GLUCOSE

ace0ca5089235ab8318b25916f408306

I
Jan 10, 2031

FETAL BOVINE SERUM (FBS)

FETAL BOVINE SERUM (FBS)

ca3d5f461811c4588436fe999493af9a

I
Jan 10, 2031

G 418 DISULFATE SALT

G 418 DISULFATE SALT

32c5ee0a4af2f1b7047999f2c1d2b6e2

I
Jan 10, 2031

GENTAMICIN SULFATE SALT

GENTAMICIN SULFATE SALT

40f8a9a693e8794a0fad88f59904ca57

I
Jan 10, 2031

HANKS’ BALANCED SALT SOLUTION (HBSS)

HANKS' BALANCED SALT SOLUTION (HBSS)

d772210015acb06acd9152fd8726dea4

I
Jan 10, 2031

BLEOMYCIN SULFATE FROM STREPTOMYCES VERTICILLUS

BLEOMYCIN SULFATE FROM STREPTOMYCES VERTICILLUS

53dd45b83e8326845567be43ad6c344e

I
Jan 10, 2031

ITS LIQUID MEDIA SUPPLEMENT (100×)

ITS LIQUID MEDIA SUPPLEMENT (100×)

70f5577e917ac9eaca8697429ba72086

I
Jan 10, 2031

KANAMYCIN MONOSULFATE FROM STREPTOMYCES KANAMYCETICUS CELL CULTURE TESTED

KANAMYCIN MONOSULFATE FROM STREPTOMYCES KANAMYCETICUS CELL CULTURE TESTED

fd0f0d6940c625a7b0f98d485338ed09

I
Jan 10, 2031

L-GLUTAMINE

L-GLUTAMINE

c16f0db8b118e0172062189f7a5453db

I
Jan 10, 2031

ERYTHROMYCIN

ERYTHROMYCIN

bda8a4573fbc3d088a660c00c610f8a0

I
Jan 10, 2031
Risk Class Distribution
Devices by risk class
I
205
81.7% of total
II
22
8.8% of total
Unspecified
15
6.0% of total
IIa
6
2.4% of total
III
3
1.2% of total